即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 1821496-27-8 | 货号 | BCP25061 |
关联产品 | 1909226-00-1(BDA-366) 142645-19-0(BDA366) | ||
中文名 | BDA-366 | ||
英文名 | BDA-366 | ||
中文别名 | |||
英文别名 | BDA 366; BDA366; | ||
SMILES | CCN(CC)C[C@@H](O)CNC1=CC=C(NC[C@@H]2OC2)C3=C1C(C4=C(C3=O)C=CC=C4)=O | ||
化学名称 | |||
分子式 | C24H29N3O4 | 分子量 | 423.51 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | BDA-366 is a BCL2-BH4 antagonist. BDA-366 suppresses human myeloma growth. BDA-366 induces robust apoptosis in MM cell lines and primary MM cells by inducing BCL2 conformational change. Delivery of BDA-366 substantially suppressed the growth of human MM xenografts in NOD-scid/IL2Rγnull mice, without significant cytotoxic effects on normal hematopoietic cells or body weight. Thus, BDA-366 functions as a novel BH4-based BCL2 inhibitor and offers an entirely new tool for MM therapy. |
相关产品推荐
查看更多 >Tags:BDA-366 供应商,BDA-366 购买,BDA-366 生产,BDA-366 批量,BDA-366 供应,BDA-366 订购,BDA-366 采购